Your browser doesn't support javascript.
loading
Randomized double-blind safety study of enoxaparin versus unfractionated heparin in patients with non-ST-segment elevation acute coronary syndromes treated with tirofiban and aspirin: the ACUTE II study. The Antithrombotic Combination Using Tirofiban and Enoxaparin.
Cohen, Marc; Théroux, Pierre; Borzak, Steven; Frey, Martin J; White, Harvey D; Van Mieghem, W; Senatore, Fred; Lis, Joy; Mukherjee, Robin; Harris, Kathy; Bigonzi, Frederique.
Affiliation
  • Cohen M; MCP Hahnemann University School of Medicine, Philadelphia, Pa, USA. marc.cohen@tenethealth.com
Am Heart J ; 144(3): 470-7, 2002 Sep.
Article in En | MEDLINE | ID: mdl-12228784
Subject(s)
Search on Google
Add to My VHL
Print
XML
PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Tyrosine / Heparin / Aspirin / Enoxaparin / Platelet Glycoprotein GPIIb-IIIa Complex / Coronary Disease / Electrocardiography / Fibrinolytic Agents / Hemorrhage Type of study: Clinical_trials / Diagnostic_studies Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Am Heart J Year: 2002 Document type: Article Affiliation country: United States
Search on Google
Add to My VHL
Print
XML
PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Tyrosine / Heparin / Aspirin / Enoxaparin / Platelet Glycoprotein GPIIb-IIIa Complex / Coronary Disease / Electrocardiography / Fibrinolytic Agents / Hemorrhage Type of study: Clinical_trials / Diagnostic_studies Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Am Heart J Year: 2002 Document type: Article Affiliation country: United States